HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide.

Abstract
Citalopram is a selective serotonin reuptake inhibitor (SSRI), widely used in the treatment of depressive disorders. It has been shown that citalopram affects seizure susceptibility. Although the exact mechanism of these effects are not yet fully understood, recent data suggest that 5HT(3) receptors and nitric oxide (NO) might participate in the central effects of SSRIs. In this study in a mouse model of clonic seizure induced by pentylenetetrazole we investigated whether 5-HT(3) receptors are involved in the effects of citalopram on seizure threshold. In our experiments, citalopram at lower doses (0.5 and 1mg/kg, i.p) significantly increased the seizure threshold and at higher doses (≥25mg/kg) showed proconvulsive effects. Moreover, mCPBG (a 5-HT(3) receptor agonist) at low and non-effective doses augmented while non-effective doses of tropisetron prevented the anticonvulsive properties of citalopram. On the other hand, Low doses of nitric oxide synthase inhibitors l-NAME and 7-NI alone or in combination with lower doses of 5-HT(3) receptor agonist enhanced the anticonvulsive property of citalopram, while l-arginine (NO precursor) alone or in combination with tropisetron blocked the protective effect of citalopram. In summary, our findings demonstrate that 5-HT(3) receptor mediates the anticonvulsant properties of low doses of citalopram, whereas it seems that the proconvulsive effect is mostly mediated through the NO pathway and can be totally blocked by NOS inhibitors. This could propose a new approach toward finding the mechanism of citalopram activity, curtailing the adverse effects of citalopram and perhaps managing the convulsions as a vicious consequence of citalopram overdose.
AuthorsBorna Payandemehr, Arash Bahremand, Reza Rahimian, Pouya Ziai, Afsaneh Amouzegar, Mohammad Sharifzadeh, Ahmad Reza Dehpour
JournalEpilepsy research (Epilepsy Res) Vol. 101 Issue 3 Pg. 217-27 (Sep 2012) ISSN: 1872-6844 [Electronic] Netherlands
PMID22578701 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Anticonvulsants
  • Biguanides
  • Enzyme Inhibitors
  • Receptors, Serotonin, 5-HT3
  • Serotonin Receptor Agonists
  • Citalopram
  • Nitric Oxide
  • 1-(3-chlorophenyl)biguanide
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester
  • Pentylenetetrazole
Topics
  • Animals
  • Anticonvulsants (pharmacology, therapeutic use)
  • Biguanides (pharmacology)
  • Citalopram (pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Male
  • Mice
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Pentylenetetrazole (adverse effects)
  • Receptors, Serotonin, 5-HT3 (metabolism)
  • Seizures (chemically induced, drug therapy, metabolism)
  • Serotonin Receptor Agonists (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: